BIO-X® Accelerate is a further development of BIO-X in close collaboration with Tillväxtverket and Region Uppsala, with Uppsala Innovation Centre as partner, with the goal to accelerate the development of innovative life-science companies in the region.
The program utilises an industrial approach to support early-stage, life-science related projects that could fulfil well-defined needs in healthcare and society. Projects receive funding, continued support and access to experts within the BIO-X network. The first critical step towards potential commercialization – ‘proof of concept’ studies should already be performed when entering the program. After BIO-X the project should be ready for investment by for example industry or venture capital companies, for a future new product, method or therapy with a significantly new value for the patients, healthcare or society. BIO-X is a trademark of STUNS Life Science (former Uppsala BIO).
Financing: STUNS Life Science, Tillväxtverket, Region Uppsala with UIC as partner
Project duration: 2019–2022
Contact: Dajana Ilic S, Kristin Hellman
STUNS Life Science’s role: Project leader